[1]
N. A. Ismail, F. A. Hadil, and M. . Mohamad, “COMPARISON OF DENOSUMAB AND ALENDRONATE EFFICACY AND RELATED DIABETES RISK IN PATIENTS WITH OSTEOPOROSIS”, J ASEAN Fed Endocr Soc, vol. 39, no. S1, p. 54, Jul. 2024.